Thank you for completing the pre-screening questionnaire for the study.
We will review your responses to check your eligibility for the study (or you will have been notified you are not eligible already at the end of the questionnaire, if applicable).
If you are selected, a study staff member will reach out to you and explain the next steps in the screening process for this study. We try to respond to all eligible queries within 7 business days.
Feel free to email us if you have any questions in the meantime: email@example.com.
Scroll down to read more about the study
LET'S DO SOMETHING ABOUT IT.
If you’re having symptoms that you think are caused by gluten, despite being on a gluten-free diet, our clinical trial could be part of the solution for you.
Join the Solutions for Celiac Study, where you get access to:
an investigational medication designed to reduce symptoms of accidental gluten cross-contact
celiac disease blood testing,
symptom reporting tools, and
celiac specialists focused on your disease.
Our dedicated study team is led by prominent celiac disease physician-researchers and will work closely with you to track your health related to celiac disease.
You may qualify to participate if you:
Are between 18 and 80 years old
Have a biopsy confirmed diagnosis of celiac disease
Have been on a gluten-free diet for the last 12 months
Have experienced at least one moderate or greater severity symptom of abdominal pain and/or bloating in the last month
Are not pregnant or actively looking to become pregnant
Have no history of drug or alcohol abuse in the last 12 months
Are willing to travel to your respective study site for up to 6 visits
Take our pre-screening survey below to find out if you qualify today. For questions or more information, please contact us.
"The goal of this upcoming NIAID-funded study is to understand if latiglutenase reduces symptoms significantly more than placebo in people who are still seropositive while on the gluten-free diet."
Approximately 50% of celiac patients are still glutened every day
The average amount of gluten accidentally still eaten on a gluten-free diet is >200 mg/day, and can be up to 36 times the recommended limit! 
Serology testing can help diagnose celiac diease.
Serology testing is a specific blood test that determines if your blood contains circulating antibodies to gluten. It is one important element of the celiac disease diagnosis process.
A drink-based study medication taken three times a day with meals.
In a previous study, patients taking latiglutenase 3 times a day with meals experienced 58% and 44% improvement in abdominal pain and bloating, respectively.